By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Stem Cell Authority, Ltd.

Stem Cell Authority, Ltd. (SCAL)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$17.42K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.03
52 Week Range

SCAL Stock Price Chart

Explore Stem Cell Authority, Ltd. interactive price chart. Choose custom timeframes to analyze SCAL price movements and trends.

SCAL Company Profile

Discover essential business fundamentals and corporate details for Stem Cell Authority, Ltd. (SCAL) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Care Facilities

IPO Date

17 Mar 2005

Employees

CEO

Carlzo Bernard Cardwell

Description

Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton's jelly inside the umbilical cord of a newborn child. The company's technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in Fairlawn, Ohio.

SCAL Financial Timeline

Browse a chronological timeline of Stem Cell Authority, Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

SCAL Stock Performance

Access detailed SCAL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run